Updated:
Lancet Capital
Lancet Capital is a Boston-based venture capital firm founded in 1998 by William Golden and George Sing, with $60 million in assets under management.
Overview
Lancet Capital is a Boston-based venture capital firm founded in 1998 by William Golden and George Sing, with $60 million in assets under management. It holds the distinction of being the first Small Business Investment Company (SBIC) affiliated with an academic medical center. The firm focuses on early-stage biomedical portfolio companies, investing in exceptional researchers, clinicians, and entrepreneurs to commercialize innovative biomedical technologies. Lancet seeks to create value for both investors and founders by actively participating in the venture-building process. Beyond capital, the firm provides value-adding human capital including startup senior management, operations expertise, business planning, management recruitment, and access to key resources and expertise. William Golden serves as Managing Director. The firm's strategy centers on bridging scientific innovation with commercial success in the biomedical sector.
General information
Firm type
Venture Capital
AUM
$60 million
Location
Country
United States
City
Boston
Corporate office
Boston, United States
Sector focus
Frequently asked questions
What is Lancet Capital's investment focus?
Lancet Capital invests in early-stage biomedical companies, backing researchers, clinicians, and entrepreneurs to commercialize innovative biomedical technologies.
What value does Lancet Capital provide beyond capital?
Lancet provides startup senior management, operations expertise, business planning, management recruitment, and access to key resources and expertise during the venture-building process.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: